Evofem Biosciences, Inc.
EVFM
Revenue
7.10M
▲2.61M▲58.01%
3 Months ChangeAssets
23.79M
▼-153.00k▼-0.6390%
3 Months ChangeLiabilities
90.26M
▲193.00k▲0.2143%
3 Months ChangeFree Cash Flow
109.00k
▲5.05M▲102.21%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-31
Form 8-K
ID: 0001493152-24-043241
2024-10-28
Form 8-K
ID: 0001493152-24-042605
2024-10-03
Form 8-K
ID: 0001493152-24-039392
2024-09-25
Form 8-K
ID: 0001493152-24-038113
2024-09-06
Form 8-K
ID: 0001493152-24-035285
2024-08-30
Form 8-K
ID: 0001493152-24-034623
2024-08-20
Form 8-K
ID: 0001493152-24-033265
2024-08-14
Form 10-Q
ID: 0001493152-24-031846
2024-08-14
Form 8-K
ID: 0001493152-24-031835
2024-07-23
Form 8-K
ID: 0001493152-24-028818